127 related articles for article (PubMed ID: 19791697)
21. Developing countries face double burden of disease.
Marshall SJ
Bull World Health Organ; 2004 Jul; 82(7):556. PubMed ID: 15500291
[No Abstract] [Full Text] [Related]
22. Economic research on HIV prevention, care and treatment: why it is more than ever needed?
Moatti JP; Eboko F
Curr Opin HIV AIDS; 2010 May; 5(3):201-3. PubMed ID: 20539074
[No Abstract] [Full Text] [Related]
23. Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
; Marlink R; Forsythe S; Bertozzi SM; Muirhead D; Holmes M; Sturchio J
AIDS; 2008 Jul; 22 Suppl 1():S121-2. PubMed ID: 18664943
[No Abstract] [Full Text] [Related]
24. [Studies on direct and indirect economic burden of disease and related factor in countryside of Qingdao city in 2001].
Zhuang RS; Wang SY; Liang WN; Jing CX; Li B; Yan B
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):196-8. PubMed ID: 12816710
[TBL] [Abstract][Full Text] [Related]
25. The global impact of noncommunicable diseases: estimates and projections.
Manton KG
World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
[TBL] [Abstract][Full Text] [Related]
26. Vertically acquired paediatric HIV infection: the challenges of providing comprehensive packages of care in resource-limited settings.
Little KE; Bland RM; Newell ML
Trop Med Int Health; 2008 Sep; 13(9):1098-110. PubMed ID: 18664240
[TBL] [Abstract][Full Text] [Related]
27. Antiretroviral therapy in resource-poor settings: scaling up inequalities?
Egger M; Boulle A; Schechter M; Miotti P
Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732
[No Abstract] [Full Text] [Related]
28. [Status report on public health in Mauritius in 2009].
D'Aoust L; Munbodh P; Sookram C; Paratian U; Gaüzère BA; Aubry P
Med Trop (Mars); 2010 Jun; 70(3):229-38. PubMed ID: 20734589
[TBL] [Abstract][Full Text] [Related]
29. Patents versus patients? Antiretroviral therapy in India.
Havlir DV; Hammer SM
N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
[No Abstract] [Full Text] [Related]
30. Scale-up of national antiretroviral therapy programs: progress and challenges in the Asia Pacific region.
Srikantiah P; Ghidinelli M; Bachani D; Chasombat S; Daoni E; Mustikawati DE; Nhan do T; Pathak LR; San KO; Vun MC; Zhang F; Lo YR; Narain JP
AIDS; 2010 Sep; 24 Suppl 3():S62-71. PubMed ID: 20926930
[TBL] [Abstract][Full Text] [Related]
31. Chronic diseases in developing countries: health and economic burdens.
Nugent R
Ann N Y Acad Sci; 2008; 1136():70-9. PubMed ID: 18579877
[TBL] [Abstract][Full Text] [Related]
32. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
[TBL] [Abstract][Full Text] [Related]
33. Parasites, people and policy: infectious diseases and the Millennium Development Goals.
May RM
Trends Ecol Evol; 2007 Oct; 22(10):497-503. PubMed ID: 17904247
[TBL] [Abstract][Full Text] [Related]
34. The marriage of science and optimized HIV care in resource-limited settings.
Calmy A; Pizzocolo C; Pizarro L; Brücker G; Murphy R; Katlama C;
AIDS; 2008 Nov; 22(17):2227-30. PubMed ID: 18981761
[No Abstract] [Full Text] [Related]
35. [Challenges to implement strategies for the primary and secondary prevention of cervical cancer in Mexico].
Lazcano-Ponce E; Allen B; Palacio-Mejía LS; Hernández-Avila M
Gac Med Mex; 2006; 142 Suppl 2():43-9. PubMed ID: 19031678
[TBL] [Abstract][Full Text] [Related]
36. Prevention of renal disease progression and renal replacement therapy in emerging countries.
Hafez MH; Abdellatif DA; Elkhatib MM
Artif Organs; 2006 Jul; 30(7):501-9. PubMed ID: 16836730
[TBL] [Abstract][Full Text] [Related]
37. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
38. Commentary: shifting burden of disease--epidemiological transition in India.
Quigley MA
Int J Epidemiol; 2006 Dec; 35(6):1530-1. PubMed ID: 17092948
[No Abstract] [Full Text] [Related]
39. Sustaining treatment costs: who will pay?
Zewdie D; De Cock K; Piot P
AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
[No Abstract] [Full Text] [Related]
40. Generic HIV drugs--enlightened policy for global health.
Wainberg MA
N Engl J Med; 2005 Feb; 352(8):747-50. PubMed ID: 15728804
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
